Jason Yaffe
Background and experience
Jason leads ZS’s global rare disease practice, where he extends ZS’s domain expertise to organizations in the development and commercialization of therapeutics for over 350 million patients. Under Jason’s leadership in the last year, the rare disease practice has supported 87 clients and 50% of global rare disease launches.
Through his extensive work with small and midsize biopharmaceutical companies, Jason has deep expertise in commercial strategy, insights and analytics, and operations—with a specific focus in business development and opportunity assessments, new product launch planning, organizational design and advanced analytics. He has worked across most major therapeutic categories including neuromuscular diseases, hematology and oncology.
Before joining ZS in 2014, Jason worked as the lead clinical research coordinator at Washington Cancer Institute at MedStar Health in Washington, D.C. He also served as a product manager, supporting a multibillion-dollar portfolio for a top-five global biopharmaceutical company.
Education
MBA in strategy and marketing, McDonough School of Business at Georgetown University
Bachelor’s degree in biochemistry, University of Maryland